{"id":"https://openalex.org/W4200217853","doi":"https://doi.org/10.1182/blood-2021-154052","title":"Crebbp Alterations Are Associated with a Poor Prognosis in De Novo AML","display_name":"Crebbp Alterations Are Associated with a Poor Prognosis in De Novo AML","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W4200217853","doi":"https://doi.org/10.1182/blood-2021-154052"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-154052","doi":"https://doi.org/10.1182/blood-2021-154052","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-154052","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043814334","display_name":"Adam J. Lamble","orcid":"https://orcid.org/0000-0002-7781-2918","observed_orcids":["https://orcid.org/0000-0002-7781-2918"]},"institutions":[{"id":"https://openalex.org/I1295499534","display_name":"Seattle Children's Hospital","ror":"https://ror.org/01njes783","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295499534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam J. Lamble","raw_affiliation_strings":["Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA","institution_ids":["https://openalex.org/I1295499534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021003209","display_name":"Robert B. Gerbing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134079","display_name":"Children's Oncology Group","ror":"https://ror.org/03yyg2352","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210134079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert B. Gerbing","raw_affiliation_strings":["Children's Oncology Group, Monrovia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group, Monrovia, CA","institution_ids":["https://openalex.org/I4210134079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050883476","display_name":"Jenny L. Smith","orcid":"https://orcid.org/0000-0003-0402-2779","observed_orcids":["https://orcid.org/0000-0003-0402-2779"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenny L. Smith","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017522276","display_name":"Rhonda E. Ries","orcid":"https://orcid.org/0000-0002-3702-7923","observed_orcids":["https://orcid.org/0000-0002-3702-7923"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rhonda E. Ries","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009981843","display_name":"Edward Anders Kolb","orcid":"https://orcid.org/0000-0003-2854-9014","observed_orcids":["https://orcid.org/0000-0003-2854-9014"]},"institutions":[{"id":"https://openalex.org/I1326254912","display_name":"Alfred I. duPont Hospital for Children","ror":"https://ror.org/00jyx0v10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1326254912","https://openalex.org/I4210108049"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward A. Kolb","raw_affiliation_strings":["Division of Oncology, Nemours Alfed I. duPont Hospital For Children, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Nemours Alfed I. duPont Hospital For Children, Wilmington, DE","institution_ids":["https://openalex.org/I1326254912"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066861312","display_name":"Todd A. Alonzo","orcid":"https://orcid.org/0000-0002-6772-6581","observed_orcids":["https://orcid.org/0000-0002-6772-6581"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I4210134079","display_name":"Children's Oncology Group","ror":"https://ror.org/03yyg2352","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210134079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd A. Alonzo","raw_affiliation_strings":["Children's Oncology Group, Monrovia, CA","University of Southern California, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group, Monrovia, CA","institution_ids":["https://openalex.org/I4210134079"]},{"raw_affiliation_string":"University of Southern California, Los Angeles, CA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049490094","display_name":"Soheil Meshinchi","orcid":"https://orcid.org/0000-0002-6276-4423","observed_orcids":["https://orcid.org/0000-0002-6276-4423"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Soheil Meshinchi","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"3451","last_page":"3451"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/creb-binding-protein","display_name":"CREB-binding protein","score":0.7919999957084656},{"id":"https://openalex.org/keywords/de-novo-acute-myeloid-leukemia","display_name":"de novo acute myeloid leukemia","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pediatric-acute-myeloid-leukemia","display_name":"pediatric acute myeloid leukemia","score":0.8880000114440918},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7059999704360962},{"id":"https://openalex.org/keywords/kat6a","display_name":"KAT6A","score":0.6510000228881836},{"id":"https://openalex.org/keywords/crebbp-mutation","display_name":"CREBBP mutation","score":0.777999997138977},{"id":"https://openalex.org/keywords/frameshift-mutation","display_name":"frameshift mutation","score":0.8550000190734863},{"id":"https://openalex.org/keywords/single-nucleotide-variants","display_name":"single nucleotide variants","score":0.9399999976158142},{"id":"https://openalex.org/keywords/indels","display_name":"indels","score":0.5429999828338623},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C119054055","wikidata":"https://www.wikidata.org/wiki/Q1576681","display_name":"Indel","level":5,"score":0.4935098886489868},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.4670865535736084},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45421209931373596},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4171103239059448},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.4148319363594055},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3933044672012329},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34664344787597656},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.28059250116348267},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18467530608177185},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.13525792956352234},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1025305688381195},{"id":"https://openalex.org/C153209595","wikidata":"https://www.wikidata.org/wiki/Q501128","display_name":"Single-nucleotide polymorphism","level":4,"score":0.0893789529800415},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-154052","doi":"https://doi.org/10.1182/blood-2021-154052","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-154052","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7200000286102295,"id":"https://metadata.un.org/sdg/1","display_name":"No poverty"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2084783894","https://openalex.org/W2033001683","https://openalex.org/W2464485693","https://openalex.org/W1981020631","https://openalex.org/W2766086379","https://openalex.org/W2091488701","https://openalex.org/W79501404","https://openalex.org/W2033604768","https://openalex.org/W1976623989","https://openalex.org/W2296580809"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"The":[2,165,577],"translocation,":[3],"t(8;16)(p11;p13),":[4],"results":[5],"in":[6,21,72,229,267,371,457,514,531,574],"the":[7,40,59,153,160,199,372,393,482,493,543,550],"fusion":[8,146],"between":[9,198,290,357,527],"KAT6A":[10,151,530],"and":[11,13,24,100,106,113,159,186,195,209,275,328,355,359,529,553],"CREBBP":[12,63,67,93,148,172,309,455,528,560],"has":[14,32],"been":[15,34],"associated":[16,249,557],"with":[17,74,150,177,188,250,307,333,375,385,438,460,501,558],"a":[18,145,171,183,189,224,251,260,312,349,376,451,470,515],"poor":[19,367,400,405,511],"prognosis":[20,484],"both":[22],"pediatric":[23,85,458],"adult":[25],"acute":[26],"myeloid":[27],"leukemia":[28],"(AML).":[29],"This":[30,366],"lesion":[31],"therefore":[33],"re-classified":[35],"as":[36],"high":[37,540,554],"risk":[38,541],"on":[39,77,344,542],"active":[41,544],"Phase":[42],"3":[43,547],"Children's":[44],"Oncology":[45],"Group":[46],"(COG)":[47],"trial":[48],"for":[49,82],"de":[50,83,461],"novo":[51,84,462],"AML,":[52,463],"AAML1831":[53],"(NCT04293562).":[54],"Less":[55],"is":[56],"known":[57],"about":[58],"prognostic":[60],"significance":[61],"of":[62,142,214,227,263,341,346,353,454,474,480,495,517,536,563,596],"sequence":[64],"variants.":[65],"Methods:":[66],"variant":[68],"status":[69,301],"was":[70,223,259,286,369,490],"determined":[71],"patients":[73,128,134,168,203,211,231,235,243,322,337,374,384,397,408,417,427,437,459,468,500,518,532],"AML":[75,86],"enrolled":[76],"4":[78],"successive":[79],"COG":[80,545],"trials":[81],"(NCT00003790,":[87],"NCT00070174,":[88],"NCT01407757,":[89],"NCT01371981).":[90],"Fusions":[91],"involving":[92,138,147,163],"were":[94,118,144,204,244,389],"prospectively":[95],"obtained":[96],"via":[97,103,121],"conventional":[98],"cytogenetics":[99],"retrospectively":[101,119],"confirmed":[102],"RNAseq.":[104],"Insertions":[105],"deletions":[107],"(indels)":[108],"leading":[109,181],"to":[110,182,233,247,321,415,581,598],"frameshift":[111,184],"mutations":[112],"single":[114],"nucleotide":[115],"variants":[116],"(SNVs)":[117],"interrogated":[120],"next":[122],"generation":[123],"sequencing.":[124],"Results:":[125],"Of":[126],"2216":[127],"(age:":[129],"0-29.8":[130],"years),":[131],"55":[132],"(2.5%)":[133],"had":[135,170,311,409],"an":[136,178,410],"alteration":[137,310,347,475,489],"CREBBP.":[139],"Sixteen":[140],"(29%)":[141],"these":[143,426,467,510],"(CREBBP/fus),":[149],"being":[152],"most":[154],"common":[155],"translocation":[156,162],"partner":[157],"(n=15)":[158],"remaining":[161,166,394],"ANK1.":[164],"39":[167],"(71%)":[169],"mutation":[173,185],"(CREBBP/mut),":[174],"including":[175,566],"19":[176],"indel":[179],"(CREBBP/indel)":[180],"20":[187],"SNV":[190],"(CREBBP/SNV).":[191],"We":[192],"compared":[193,232,320],"clinical":[194],"biologic":[196],"characteristics":[197],"three":[200],"cohorts.":[201],"CREBBP/fus":[202,358,439],"significantly":[205,313],"younger":[206],"than":[207],"CREBBP/indel":[208,230,268,373],"CREBBP/SNV":[210,234,242,276],"(median":[212],"ages":[213],"2.6":[215],"vs.":[216,218,237,255,325,419],"7.8":[217],"11.9":[219],"years;":[220],"p=0.027).":[221],"There":[222,258,285],"higher":[225],"prevalence":[226,262],"t(8;21)/RUNX1-RUNX1T1":[228],"(42.1%":[236],"5%;":[238],"p=0.008).":[239],"In":[240,434,450],"contrast,":[241,435],"more":[245],"likely":[246],"be":[248,429,522,572],"normal":[252],"karyotype":[253],"(40%":[254],"5.3%;":[256],"p=0.02).":[257],"similar":[261,350],"co-occurring":[264,377,386,502],"high-risk":[265,336,387,503],"lesions":[266,388,504],"(n=5;":[269],"CBFA2T3-GLIS2,":[270],"KMT2A-AFF1,":[271],"KMT2A-MLLT4,":[272],"MLLT10-PICALM,":[273],"NUP98-HOXA9)":[274],"(n=7;":[277],"DEK-NUP214,":[278],"ETV6-FOXO1,":[279],"FUS-ERG,":[280],"NUP98-NSD1,":[281],"ETV6-MNX1,":[282],"FLT3-ITDx2)":[283],"patients.":[284],"otherwise":[287,521],"no":[288],"difference":[289],"presenting":[291],"WBC":[292],"count,":[293],"FLT3-ITD,":[294],"NPM1,":[295],"CEBPA,":[296],"remission":[297],"rates":[298,556],"or":[299],"MRD":[300],"after":[302],"Induction":[303],"1":[304,589],"therapy.":[305],"Patients":[306],"any":[308],"worse":[314],"5-year":[315,351,380],"event":[316],"free":[317],"survival":[318,413],"(EFS)":[319],"without":[323],"(25.9%":[324],"45.2%;":[326],"p=0.002)":[327],"this":[329,488,575],"inferior":[330,551],"EFS":[331,352,368,381,401,552],"overlaps":[332],"contemporarily":[334],"defined":[335],"(Figure":[338,363],"1a).":[339],"Evaluation":[340],"outcomes":[342,512],"based":[343],"type":[345],"demonstrated":[348],"33.3%":[354],"23.1%":[356],"CREBBP/mut":[360,395,407],"patients,":[361],"respectively":[362],"1b;":[364],"p=0.832).":[365],"maintained":[370,398],"t(8;21)":[378],"(n=8,":[379],"12.5%).":[382],"When":[383],"excluded":[390],"from":[391,444,505],"analysis,":[392,506],"(n=27)":[396],"their":[399,404,445],"(29.6%).":[402],"Despite":[403],"EFS,":[406,472],"analogous":[411],"overall":[412],"(OS)":[414],"non-CREBBP":[416],"(57.4%":[418],"62.3%;":[420],"p=0.499,":[421],"Figure":[422,588,590],"1c),":[423],"demonstrating":[424],"that":[425,440,466,509,519],"could":[428],"successfully":[430],"salvaged":[431],"following":[432],"relapse.":[433],"all":[436],"relapsed":[441],"subsequently":[442],"died":[443],"disease":[446],"(OS":[447],"33.3%).":[448],"Conclusions:":[449],"large":[452],"study":[453],"alterations":[456],"we":[464,507],"show":[465,508],"have":[469],"dismal":[471],"regardless":[473],"type.":[476],"Further,":[477],"despite":[478],"enrichment":[479],"t(8;21),":[481],"favorable":[483],"typically":[485],"conferred":[486],"by":[487,492,498],"abrogated":[491],"co-occurrence":[494],"CREBBP/indel.":[496],"Similarly,":[497],"excluding":[499],"persist":[513],"cohort":[516],"would":[520,579],"considered":[523,539,573],"low":[524],"risk.":[525],"Translocations":[526],"over":[533],"90":[534],"days":[535],"age":[537],"are":[538],"phase":[546],"trial.":[548],"Given":[549],"salvage":[555],"other":[559],"alterations,":[561],"intensification":[562],"upfront":[564],"treatment,":[565],"hematopoietic":[567],"stem":[568],"cell":[569],"transplant,":[570],"should":[571],"population.":[576],"authors":[578],"like":[580],"acknowledge":[582],"Astellas":[583],"Pharma":[584],"Global":[585],"Development,":[586],"Inc.":[587],"1.":[591],"Disclosures":[592],"No":[593],"relevant":[594],"conflicts":[595],"interest":[597],"declare.":[599]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}